Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.

[1]  G. Riou,et al.  In vitro chemical eradication of small cell lung cancer: application in autologous bone marrow transplantation. , 1988, European journal of cancer & clinical oncology.

[2]  Y. Humblet,et al.  Chapter 22 Cytotoxicity of workshop monoclonal antibodies in the presence of complement , 1988 .

[3]  P. Hervé,et al.  Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow. , 1988, Experimental hematology.

[4]  J. Canon,et al.  Detection of small cell lung cancer bone marrow metastases by immunofluorescence. , 1988, Pathologie-biologie.

[5]  Y. Humblet,et al.  Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30. , 1988, Bone marrow transplantation.

[6]  J. Machiels,et al.  Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  K. Anderson,et al.  Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. , 1987, The New England journal of medicine.

[8]  O. Colvin,et al.  Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. , 1986, The New England journal of medicine.

[9]  J. Minna,et al.  Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. , 1986, Cancer research.

[10]  T. Lebien,et al.  Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamid (ASTA Z 7557). , 1986, Leukemia research.

[11]  R. Stahel,et al.  Selective cytotoxicity of murine monoclonal antibody LAM2 against human small‐cell carcinoma in the presence of human complement: Possible use for in vitro elimination of tumor cells from bone marrow , 1985, International journal of cancer.

[12]  R. Stahel,et al.  Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung. , 1985, The Journal of clinical investigation.

[13]  K. Ozawa,et al.  Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody. , 1985, Cancer research.

[14]  R. Stahel,et al.  Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R. Stahel,et al.  Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung. , 1985, Cancer research.

[16]  T. Boon,et al.  Use of irradiated mouse fibroblasts to improve the cloning and adaptation to culture of human melanoma cells , 1985, International journal of cancer.

[17]  J. Minna,et al.  Small cell lung cancer 1973-1983: early progress and recent obstacles. , 1984, International journal of radiation oncology, biology, physics.

[18]  Y. Humblet,et al.  Immunological removal of cancer cells in bone marrow autografts: setting the experimental conditions , 1984 .

[19]  G. Hale,et al.  Advantages of rat monoclonal antibodies. , 1983, Immunology today.

[20]  M. Körbling,et al.  4‐Hydroperoxyclophosphamide: a model for eliminating residual human tumour cells and T‐lymphocytes from the bone marrow graft , 1982, British journal of haematology.

[21]  J. Minna,et al.  Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium. , 1980, Cancer research.

[22]  I. Lefkovits.  Limiting Dilution Analysis , 1979 .